Roche blood test could help ‘personalize’ cancer immunotherapy – Nasdaq
Nasdaq |
Roche blood test could help 'personalize' cancer immunotherapy
Nasdaq Evidence shows that tumours with more mutations are more likely to respond to immunotherapy, Roche said, adding that it hoped its and Foundation's new test would improve measuring TMB where invasive tumour biopsies that can be tough to evaluate are … |
